Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: A population-based study

Menopause

Volumn 14, Issue 6, 2007, Pages 1039-1046

  Lindh Åstrand, Lotta ^a   Brynhildsen, Jan ^a   Hoffmann, Mikael ^a   Kjellgren, Karin I ^b   Hammar, Mats ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hormone therapy; Knowledge; Menopause; Reproduction physiology

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DATA ANALYSIS; EDUCATION; ESTROGEN SYNTHESIS; FEMALE; FERTILITY; GROUPS BY AGE; HEART INFARCTION; HORMONAL THERAPY; HOT FLUSH; HUMAN; MENOPAUSE; MENSTRUATION; NORMAL HUMAN; OSTEOPOROSIS; QUESTIONNAIRE; REPRODUCTION; RISK BENEFIT ANALYSIS; SWEATING; SWEDEN; THROMBOSIS;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCTION; SWEDEN;

EID: 36148992287     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31803816ca     Document Type: Article

References (39)

1. Hammar M, Berg G, Fåhraeus L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1984;6:345-350.
2. McKinlay S, Brambilla D, Posner J. The normal menopause transition. Maturitas 1992;14:103-115.
3. Ekblad S, Bergendahl A, Enler P, Ledin T, Möller C, Hammar M. Disturbances in postural balance are common in postmenopausal women with vasomotor symptoms. Climacteric 2000;3:192-198.
4. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-1776.
5. Criqui M, Squarez L, Barrett-Connor E, McPhillips J, Wingard D, Garland C. Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am J Epidemiol 1988;128:606-614.
6. Cauley J, Seeley D, Browner W, et al. Estrogen replacement therapy and mortality among older women: a study of osteporotic fractures. Arch Intern Med 1997;157:2181-2187.
7. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 2001;4:58-74.
8. Birkhäuser M. Menopause in the aging society. In: Aso T, Yanaihara T, Fujimota S, eds. The Menopause at the Millennium. New York, NY: Parthenon Publishing Group, 2000:101-107.
9. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Åstrand L, Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:130-154.
10. Ekström H. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 2005;52:154-164.
11. MacLennan AH, Taylor AW, Wilson DH. Hormone therapy use after the Women's Health Initiative. Climacteric 2004;7:138-142.
12. Lawton B, Rose S, Mc Leod D, Dowell A. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. BMJ 2003;327:845-846.
13. Haas JS, Kaplan CP, Gerstenberger EP, Kerlokowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184-188.
14. Hersch AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
15. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
16. Herrington DM, Vittinghoff E, Lin F, et al, for the HERS Study Group. Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002;105:2962-2967.
17. Writing Group for the Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
18. Sturdee DW, MacLennan AH. The pendulum swings back; estrogen is now beneficial if started at right time. Climacteric 2006;9:73-74.
19. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-813.
20. Nelson H, Vesco K, Haney E, et al. Nonhormonal therapies for menopausal hot flashes. JAMA 2006;295:2057-2071.
21. Stadberg E, Mattsson LÅ, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynaecol Scand 1997;76:442-448.
22. Breslau ES, Davis WW, Doner L, et al. The hormone therapy dilemma: women respond. J Am Med Women Assoc 2003;58:33-43.
23. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-1232.
24. Blümel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone therapy on postmenopausal women's health perceptions. Menopause 2003;10:235-240.
25. Strothmann A, Schneider PG. Hormone therapy: the European women's perspective. Climacteric 2003;6:337-346.
26. Thunell L, Stadberg E, Milsom I, Mattsson L-Å. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand 2005;84:395-401.
27. Lindh-Åstrand L, Brynhildsen J, Hoffmann M, Hammar M. Attitudes towards the menopause and hormone therapy over the turn of the century. Maturitas 2007;56:12-20.
28. Topo P, Luoto R, Hemminki E, Uutela A. Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999;32:141-145.
29. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Am J Epidemiol 1996;143:971-978.
30. Sogaard AJ, Tollan A, Berntsen GK, Fonnebo V, Magnus JH. Hormone replacement therapy: knowledge, attitudes, self-reported use - and sales figures in Nordic women. Maturitas 2000;35:201-214.
31. Connelly MT, Rusinak D, Livingstone W, Raeke L, Inui TS. Patient knowledge about hormone replacement therapy: implications for treatment. Menopause 2000;7:266-272.
32. Björn I, Bixo M, Nöjd KS, Nyberg S, Bäckström T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 2000;183:1419-1426.
33. Björn I, Bäckström T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32:77-86.
34. Buick DL, Crook D, Horne R. Women's perception of hormone replacement therapy: risks and benefits (1980-2002). A literature review. Climacteric 2005;8:24-35.
35. Roberts P. The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy. Br J Gen Pract 1991;41:421-424.
36. Hunter M, Liao KL. Intentions to use hormone replacement therapy in a community sample of 45-year-old women. Maturitas 1994;20:13-23.
37. Hunter M, O'Dea I. An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health. Patient Educ Couns 1999;38:249-255.
38. O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing treatment or screening decisions: systematic review. BMJ 1999;319:731-734.
39. Sydsjö G, Ekholm K, Nyström K, Oscarsson C, Kjellberg S. Knowledge of the reproduction in teenagers and young adults in Sweden. Eur J Contracept Reprod Health Care 2006;11:117-125.